With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Endocrine Disrupting Pesticides, Neonatal Hormones and Risk of Testicular Germ Cell Tumors||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2018||California|
|Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy||Massachusetts General Hospital / Bakhos Tannous, PhD||Innovation Grants||2018||Massachusetts|
|Nuclear Receptor Tyrosine Kinases Mediating Chromatin Remodeling & Checkpoint Adaption||Children's Cancer Therapy Development Institute / Charles Keller, MD||Innovation Grants||2018||Oregon|
|Circulating Repetitive Element RNAs as an Osteosarcoma Marker||Children's Hospital Los Angeles / David Cobrinik, MD/PhD||Innovation Grants||2018||California|
|Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity||University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD||Innovation Grants||2018||Texas|
|Targeting KDM6B in Pediatric Leukemia||Washington University / Grant A. Challen, PhD||Innovation Grants||2018||Missouri|
|Molecular Landscape for Targeted Therapy in Retinoblastoma||University of Miami / James Harbour, MD||Innovation Grants||2018||Florida|
|Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma||Baylor College of Medicine / Jason Yustein, MD/PhD||Innovation Grants||2018||Texas|
|Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma||Stanford University / Julien Sage, PhD||Innovation Grants||2018||California|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|